We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
The company also manufactures a range of recombinant enzyme and recombinant protein products. Including trypsin, carboxypeptidase, kinase, all-around nuclease, DNase I, T7 RNA polymerase, vaccinia cap enzyme, methyltransferase, inorganic pyrophosphatase, RNase inhibitor and other covered protease, nucleic acid production and processing enzyme products.
All products are produced with low endotoxin E. coli CleanTAK strain expression, very low endotoxin content, and do not contain any pathogens of animal origin, a wide range of application, production process in accordance with GMP specifications, can be supplied in large quantities. Some products are listed below. Please contact us for product details and more.
Recombinant bovine enterokinase
Recombinant totipotent nuclease
Recombinant T7 RNA polymerase
Recombinant human RNase inhibitors
Recombinant vaccinia hat enzyme
Recombinant methyltransferase
Recombinant yeast inorganic pyrophosphatase
Recombinant person DNase I
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
![TD-D 0.01g [Square Pan]](https://eimg.pharmasources.com/img_Cphi_en/Product/2019_12/Mimg_1912300117197629.jpg!145)
